Timothy P. Walbert - 01 Oct 2022 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Director
Signature
/s/ Michael Diem, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
01 Oct 2022
Transactions value $
$0
Form type
4
Filing time
03 Oct 2022, 16:07:00 UTC
Previous filing
03 Jun 2022
Next filing
29 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +39.7K $0.00 39.7K 01 Oct 2022 Common Stock 39.7K $9.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Century Therapeutics, Inc. (the "Company") issued Mr. Walbert stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to Mr. Walbert's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.